Mongoose Bio
Houston, US · Founded 2023 · Delaware corporation
Mongoose Bio is a company focused on T-cell therapies for cancer, drawing on research into antigen-specific CD8+ T cells, IL-21 priming, and adoptive cell transfer for tumors such as melanoma and Merkel cell carcinoma.
Founders & leadership
Mongoose Bio was founded in 2023 by Cassian Yee.
CY
Cassian YeeFounder
PH
Peter HoangNamed on SEC filing
NM
Norman Michael GreenbergNamed on SEC filing
SS
Shailbala SinghNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1M disclosed across 1 round · 2023
▶$1MraisedOct 2023 · 1 investors · BiotechnologyRule 506(b)
▶$1MraisedOct 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Cassian YeeExecutive Officer, Director, Promoter
- Peter HoangDirector, Promoter
- Norman Michael GreenbergExecutive Officer, Director, Promoter
- Shailbala SinghExecutive Officer, Promoter
- Offering amount
- $3M
- Amount sold
- $1M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 10
by search overlapMacrogenics Inc6 shared keywordsMacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer patients. It advances a pipeline of product candidates using proprietary platforms for antibody-drug conjugates, bispecific checkpoint antibodies, and T-cell engagers.
LifeMine Therapeutics6 shared keywordsLifeMine is a biopharmaceutical company that uses data science and advanced methods to accelerate drug discovery and develop precision medicines across therapeutic areas.
Mammoth Biosciences5 shared keywordsMammoth Bio develops technology to read and write the code of life, operating in the biotechnology sector.
Magnet Biomedicine4 shared keywordsMagnet Biomedicine develops TrueGlue™, a molecular glue discovery platform for designing small molecule therapeutics that induce novel protein-protein interactions to treat cancer and immune disorders. The platform systematically identifies molecular glues capable of targeting historically difficult-to-drug proteins in precision medicine.
Mustang Bio4 shared keywordsMustang Bio in-licenses and develops next-generation therapies aimed at treating patients, operating in the biotechnology and therapeutics sector.
Transcode Therapeutics4 shared keywordsTransCode Therapeutics is a clinical-stage company developing immuno-oncology and RNA-based therapeutics for high-risk and advanced cancers. Its lead candidate, TTX-MC138, targets microRNA-10b to treat patients with metastatic cancer and is in Phase 2a clinical trials.
Carmine Therapeutics4 shared keywordsCarmine Therapeutics develops gene therapies using non-viral gene transfer vector systems based on extracellular vesicle technology. The company works on delivering genetic medicines and is affiliated with academic research from institutions including MIT and the National University of Singapore.
Thymmune4 shared keywordsThymmune Therapeutics develops a machine learning-driven thymic cell engineering platform that mass-produces iPSC-derived thymic cells to restore immune function affected by aging and disease. The company is building a pipeline of off-the-shelf cell therapies for immunodeficiencies, transplant-related, and autoimmune disorders.
Minerva Biotechnologies4 shared keywordsMinerva Biotechnologies develops cancer and stem cell therapeutics, including cancer immunotherapies aimed at solid tumors and preventing cancer metastasis. The company also works on patient-derived stem cells for regenerative medicine.
Marengo Therapeutics4 shared keywordsMarengo Therapeutics is a clinical-stage biotech company developing TCR-targeting antibodies that activate specific T cell subsets by targeting Variable β (Vβ) chain variants of the T cell receptor. Its approach aims to modulate the immune system to treat cancer and other diseases.
Companies competing with Mongoose Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Mongoose Bio do?
- Mongoose Bio is a company focused on T-cell therapies for cancer, drawing on research into antigen-specific CD8+ T cells, IL-21 priming, and adoptive cell transfer for tumors such as melanoma and Merkel cell carcinoma.
- Who founded Mongoose Bio?
- Mongoose Bio was founded by Cassian Yee in 2023.
- How much funding has Mongoose Bio raised?
- Mongoose Bio has disclosed $1M raised across 1 round.
- Where is Mongoose Bio headquartered?
- Mongoose Bio is headquartered in Houston, US.